LONDON (Reuters) - U.S. pharmaceuticals giant Bristol-Myers Squibb (BMY.N) has hired two banks to find a buyer for its French over-the-counter (OTC) drugs business, which could be valued at more than 1 billion euros in a potential deal, sources familiar with the matter told Reuters.